Does p53 affect organismal aging?

Journal of Cellular Physiology

Volumn 192, Issue 1, 2002, Pages 23-33

  Donehower, Lawrence A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

AGING; APOPTOSIS; CANCER RESISTANCE; CELL AGING; CELL CYCLE; HUMAN; LONGEVITY; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; STEM CELL;

AGING; ANIMALS; CELL AGING; CELL DIVISION; HUMANS; MICE; MICE, MUTANT STRAINS; MODELS, BIOLOGICAL; STEM CELLS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036260527     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10104     Document Type: Review

References (151)

1. Genetically engineered mice and their use in aging research
2. Mutant and genetically modified mice as models for studying the relationship between aging and carcinogenesis
3. Post-translational modifications and activation of p53 by genotoxic stresses
4. Human Aging
5. A critical role for telomeres in suppressing and facilitating carcinogenesis
6. Regulation of p53 stability
7. Increased activity of p53 in senescing fibroblasts
8. ENU mutagenesis: Analyzing gene function in mice
9. Growth hormone and aging
10. Delayed aging in Ames dwarf mice. Relationships to endocrine function and body size
11. Age-related changes in osteogenic stem cells in mice
12. Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: Aneuploidy and immortalization
13. Switching and signaling at the telomere
14. Physical and functional interaction between p53 and the Werner's syndrome protein
15. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA
16. Extension of life-span by introduction of telomerase into normal human cells
17. Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SDI1/WAF1
18. Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence
19. p53 modulates the exonuclease activity of Werner syndrome protein
20. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts
21. Replicative senescence: An old lives' tale?
22. Aging and cancer: The double-edged sword of replicative senescence
23. From cells to organisms: Can we learn about aging from cells in culture?
24. Cellular senescence as a tumor-suppressor mechanism
25. Piecing together the p53 puzzle
26. Role of p53 and p21 waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs
27. Genetic regulation of primitive hematopoietic stem cell senescence
28. Uncoupling the senescent phenotype from telomere shortening in hydrogen peroxide-treated fibroblasts
29. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis
30. Thymocyte apoptosis induced by p53-dependent and independent pathways
31. Regulation of p53 stability and activity in response to genotoxic stress
32. Assessment of growth parameters and life span of GHR/BP gene-disrupted mice
33. Dynamic changes in mouse hematopoietic cell numbers during aging
34. Genetic analysis of hematopoietic cell cycling in mice suggests involvement in organismal life span
35. The age of cancer
36. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cipl in normal human fibroblasts
37. A biomarker that identifies senescent human cells in culture and in aging skin in vivo
38. Regulation of a senescence checkpoint response by the E2F1 transcription factor and pl4(ARF) tumor suppressor
39. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
40. p21/p53, cellular growth control and genomic integrity
41. The price oftumour suppression?
42. PML is induced by oncogenic ras and promotes premature senescence
43. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production
44. Stem cells: New lease on life
45. Age- and stage-specific regulation patterns in the hematopoietic stem cell hierarchy
46. The complexity of p53 modulation: Emerging patterns from divergent signals
47. Reinitiation of DNA synthesis and cell division in senescent human fibroblasts by microinjection of anti-p53 antibodies
48. Replicative senescence: The human fibroblast comes of age
49. Induced senescence in HeLa cervical carcinoma cells containing elevated telomerase activity and extended telomeres
50. Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases
51. Sir2 links chromatin silencing, metabolism, and aging
52. Genetic pathways that regulate ageing in model organisms
53. The hallmarks of cancer
54. Telomeres shorten during ageing of human fibroblasts
55. Telomerase, cell immortality, and cancer
56. Potential misinterpretations using models of accelerated aging
57. Animal models showing "accelerated aging" are more likely to be useful for pathology than for mechanisms of aging
58. Selection for maximum longevity in mice
59. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice
60. The cell biology of aging
61. The future of ageing
62. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability
63. In vitro study of the mechanisms of senescence acceleration
64. Small peptides activate the latent sequence-specific DNA binding function of p53
65. Covalent and noncovalent modifiers of the p53 protein
66. Longevity, genes, and aging
67. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
68. Capitalizing on large-scale mouse mutagenesis screens
69. Mouse ENU mutagenesis
70. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2
71. Participation of p53 protein in the cellular response to DNA damage
72. Telomere structure and telomerase expression during mouse development and tumorigenesis
73. Why do we age?
74. Maximum life spans in mice are extended by wild strain alleles
75. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging
76. Mutation of the mouse klotho gene leads to a syndrome resembling ageing
77. High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene
78. A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity
79. Tumorigenic effect of nonfunctional p53 or p21 in mice mutant in the Werner syndrome helicase
80. Essential role of mouse telomerase in highly proliferative organs
81. p53, the cellular gatekeeper for growth and division
82. Analysis of ku80-mutant mice and cells with deficient levels of p53
83. p53 mediates permanent arrest over multiple cell cycles in response to gamma-irradiation
84. Dial 9-1-1 for p53: Mechanisms of p53 activation by cellular stress
85. Mutations in the WRN gene in mice accelerate mortality in a p53-null background
86. p53 is required for radiation-induced apoptosis in mouse thymocytes
87. p53 sends nucleotides to repair DNA
88. MDM2 function
89. Negative control of p53 by Sir2alpha promotes cell survival under stress
90. Evolution of Shc functions from nematode to human
91. Lessons from human progeroid syndromes
92. Replicative life-span of cultivated human cells. Effects of donor's age, tissue, and genotype
93. Possible mechanisms underlying the antiaging actions of caloric restriction
94. Mechanisms of switching on p53: A role for covalent modification?
95. The p66shc adaptor protein controls oxidative stress response and life span in mammals
96. Announcement: Four-way cross mouse stocks: A new, genetically heterogeneous resource for aging research
97. Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts
98. MDM2-master regulator of the p53 tumor suppressor protein
99. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
100. Identification of an additional negative regulatory region for p53 sequence-specific DNA binding
101. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
102. Cellular aging in Werner's syndrome: A unique phenotype?
103. Long-term culture of lymphohematopoietic stem cells
104. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras
105. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
106. Signaling to p53: Breaking the MDM2-p53 circuit
107. The p53 pathway
108. Longevity, stress response, and cancer in aging telomerase-deficient mice
109. Senescence as a mode of tumor suppression
110. Does functional depletion of stem cells drive aging?
111. Reactivation of mutant p53 through interaction of a C-terminal peptide with the core domain
112. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
113. A role for both RB and p53 in the regulation of human cellular senescence
114. Tumor surveillance via the ARF-p53 pathway
115. The INK4a/ARF network in tumour suppression
116. Cellular senescence: Mitotic clock or culture shock?
117. The ARF/p53 pathway
118. Retroviral transduction of hematopoietic progenitor cells with mutant p53 promotes survival and proliferation, modifies differentiation potential and inhibits apoptosis
119. Replicative senescence: Implications for in vivo aging and tumor suppression
120. Oxidative stress, caloric restriction, and aging
121. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism
122. Mouse and rat genotype choices
123. T-loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang
124. Telomerase and human tumorigenesis
125. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53
126. Aging mechanisms
127. Senescence-accelerated mouse (SAM): A biogerontological resource in aging research
128. A new murine model of accelerated senescence
129. Senescence-accelerated mouse (SAM): A novel murine model of senescence
130. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans
131. Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes
132. p53 mutant mice that display early ageing-associated phenotypes
133. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span
134. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase
135. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase
136. Somatic mutations and aging: A re-evaluation
137. Deletion of Ku86 causes early onset of senescence in mice
138. Surfing the p53 network
139. p53: Death star
140. Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage
141. Role ofpl4(ARF) in replicative and induced senescence of human fibroblasts
142. The retardation of aging by caloric restriction: Studies in rodents and primates
143. Stem cells; units of development, units of regeneration, and units in evolution
144. Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity
145. Pleiotropy, natural selection and the evolution of senescence
146. p53 and E2F-1 cooperate to mediate apoptosis
147. Human endothelial cell life extension by telomerase expression
148. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
149. Identification and classification of p53-regulated genes
150. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays
151. Senescence of human fibroblasts induced by oncogenic Raf